UNIGE document Scientific Article
previous document  unige:55485  next document
add to browser collection

Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection

Culley, Fiona
Hu, Kefei
Morein, Bror
Openshaw, Peter
Published in Microbes and infection. 2004, vol. 6, no. 7, p. 666-75
Abstract To protect against human respiratory syncytial virus (hRSV)-induced bronchiolitis in early infancy, vaccines need to be designed which are effective in the neonatal period. To test the safety and efficacy of adjuvants in neonatal mice, we injected hRSV surface proteins combined with immune-stimulating complexes (ISCOMs) prepared from fractions A, C or A + C of Quillaja saponins. All were well tolerated in adults, but A + C ISCOMS proved lethal in neonates; A or C fractions alone were well tolerated by neonates up to the adult dose. hRSV-ISCOM A induced antibody responses similar to combined fractions, and potent in vitro cytotoxic T cell responses. Adult-like in vitro cytotoxicity against hRSV-infected targets and precursor cytotoxic T cell frequencies were observed within one week of neonatal priming and hRSV-ISCOM A-primed neonates showed virtually complete protection against subsequent viral challenge. hRSV challenge was associated with some pulmonary eosinophilia in both age groups, with higher IL-4 production by lung CD4+ T cells in mice primed as neonates. This was, however, accompanied by only minor (approximately 10%) and transient illness and weight loss. Thus, the identification of hRSV antigen delivery systems with an age-appropriate adjuvanticity/reactogenicity balance may be feasible even in the vulnerable early-life period.
Keywords Adjuvants, Immunologic/administration & dosage/adverse effects/therapeutic useAnimalsAnimals, NewbornAntibodies, Viral/bloodBronchiolitis, Viral/prevention & control/virologyHumansISCOMs/administration & dosage/adverse effects/therapeutic useImmunizationMiceMice, Inbred BALB CRespiratory Syncytial Virus Infections/prevention & control/virologyRespiratory Syncytial Virus Vaccines/administration & dosage/adverse effects/therapeutic useRespiratory Syncytial Virus, Human/immunologySaponins/administration & dosage/chemistry/therapeutic useT-Lymphocytes/immunology
PMID: 15158774
Full text
Article (Published version) (250 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Centre de Vaccinologie et d'Immunologie néonatale (177)
(ISO format)
REGNER, Matthias et al. Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection. In: Microbes and infection, 2004, vol. 6, n° 7, p. 666-75. doi: 10.1016/j.micinf.2004.03.005 https://archive-ouverte.unige.ch/unige:55485

403 hits

0 download


Deposited on : 2015-04-13

Export document
Format :
Citation style :